Enrolling
Mapping Opportunities for HPV Vaccination and Screening Engagement and Uptake in Trans Men and Gender Non-Binary Individuals Assigned Female at Birth
Learn MoreEnrolling
Promoting Mental Health and Reducing HIV Risk Behaviours through Self-compassion, Mindful Acceptance & Resilience Transformation (SMART): An Evidence-informed Pilot Randomized Trial with Diaspora MENA Gay, Bisexual and Trans Youth in Ontario
Learn MoreEnrolling
Reporting
Optimizing HIV prevention for sexual and gender minorities seeking mental health supports: A feasibility study
Learn MoreOngoing
Drug-drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV
Learn MoreCompleted
Transgender women removing healthcare barriers to engagement in the HIV prevention and care cascades
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
